{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-26-000214","form_type":"8-K","ticker":"ARCT","cik":"0001768224","company_name":"Arcturus Therapeutics Holdings Inc.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.114174+00:00","generated_at":"2026-05-15T22:18:46.708739+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arcturus FY2025 net loss narrows to $65.8M; revenue falls 46% to $82M; CF program advances","bullets":["Q4 net loss $29.1M ($1.03/shr) vs $30.0M loss prior year; FY net loss $65.8M ($2.40/shr) vs $80.9M.","Revenue Q4 $7.2M, FY $82.0M, down $70.3M YoY due to lower CSL collaboration milestones and supply activity.","Cash $232.8M at Dec 31, 2025; cash runway extended into Q2 2028.","ARCT-032 (CF) third cohort (15 mg, 28 days) safe; 12-week Phase 2 study to start H1 2026.","KOSTAIVE COVID-19 vaccine granted UK MHRA approval in Jan 2026; BARDA pandemic flu vaccine shows durable immune response."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-26-000214","json":"https://secwatch.observer/filing/0001193805-26-000214.json","markdown":"https://secwatch.observer/filing/0001193805-26-000214.md","text":"https://secwatch.observer/filing/0001193805-26-000214.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768224/000119380526000214/0001193805-26-000214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768224/000119380526000214/e665201_8k-arct.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:18:46.708739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}